Subscribe or Manage Preferences

Burt Zweigenhaft, BS

President, CEO

Mr. Zweigenhaft is a senior key opinion leader with extensive experience in a broad spectrum of pharmaceutical and healthcare service markets, including wholesale, retail, chain, mail, PBM, specialty, infusion, oncology, disease management, managed care, Medicare, Medicaid, genetic theranostic diagnostics, and health informatics.

  Today, he is the CEO of Onco360, The Oncology Pharmacy, with corporate offices in New York City and operating five national oncology pharmacy dispensing sites. OncoMed is focused on providing national oncology pharmacy services to 1600 hematologists and oncologists and Cancer Centers of Excellence across the United States in coordination with managed care payer and limited distribution pharmaceutical access contracts. 

He is also Managing Partner of BioPharma Partners LLC; a New York City-based consulting and early-stage investment company focused on incubating pharmaceutical and healthcare-related technologu service sector companies. BioPharma Partners under his guidance has supported several pharmaceutical and technology companies with launch and contracting strategies, such as Genzyme, Alexion, Bayer. OnCallData, Monogram, and Genomic Health. 

Mr. Zweigenhaft previously served as Senior Vice President of Managed Care Sales and Marketing, Government Programs, Trade Relations, and Business Development Strategies for Priority Healthcare Corporation, a publicly traded company in the biopharmaceutical specialty pharmacy with $2.3 billion in revenues, acquired by Express Scripts in 2005. During his tenure at Priority Healthcare, managed care and government programs market share grew to over 40% with 175 contracts, covering 100 million lives and servicing 125,00 physician specialists managing an average of 85,00 patients monthly. 

Prior to joining Priority Healthcare in 2002, he spent several years serving as a specialty pharmacy consultant to Medco, CuraScript, BioScrip, and several Blue Cross Blue Shield and National Managed Care Payors.

Mr Zweigenhaft holds a Bachelor of Science degree in Management and Economics from the University of Buffalo School of Management, where he also serves on the Dean's Advisory Committee and is active within the University of Buffalo School of Pharmacy, Center for BioInformatics, and Computational Sciences programs. He is a member if the Academy of Managed Care Pharmacy, Hematology Oncology Pharmacy Association, and American Society of Clinical Oncology. He also serves on the editorial boards of industry publications, The Oncology Pharmacist, The Oncology Nurse-APN/PA, Multidisciplinary Oncology, and is Co-Chairman of AVBCC. 

Mr. Zweigenhaft also serves on the Executive Board of Swim Across America for Cancer ($36 million raised to date), where he is responsible for corporate funding. 

Last modified: April 23, 2015
  • American Health & Drug Benefits
  • Academy of Oncology Nurse Navigators
  • JONS
  • Lynx CME
  • The Oncology Nurse
  • Oncology Practice Management
  • Personalized Medicine in Oncology
  • Value-Based Cancer Care